Skip to main content
Article
Final height in children with medulloblastoma treated with growth hormone.
All Scholarly Works
  • Edward Reiter, MD, Baystate Health
Document Type
Article, Peer-reviewed
Publication Date
1-1-2005
Abstract
BACKGROUND: Medulloblastoma is the most frequent primary solid central nervous system tumour in children. The 5-year survival rate is at present at about 60%. Height in general is severely compromised in survivors. The present study is an extension of the
Publication ISSN
0002-9378
Citation Information
Horm Res 2005;64(1):28-34. Epub 2005 Aug 11.